Living Well – Vaccine reality check
A monumental hearing is set for today: an advisory panel will decide whether or not to grant emergency use authorization to Pfizer for its COVID-19 vaccine candidate.
If the panel votes to do so, the decision moves to the FDA itself. And if approved, federal officials say they plant to start vaccinating the first group of Americans within days.
Doing so, though, comes with challenges of its own.
Today’s Living Well explains.